Since 2013, the Cortellis team has produced the annual Drugs to Watch report.
In this webinar, you will gain more insights into the report. Understand the top drugs expected to launch in 2019 and achieve blockbuster sales of >$1 billion by 2023.
Based on the selection criteria for 2019, seven drugs were identified as potential blockbusters. The disease areas represented are primarily genetic diseases and autoimmune & excessive immune responses.